臨床試驗用品市場規模、佔有率和成長分析（按階段、產品/服務、最終用途、治療領域和地區分類）－2026-2033年產業預測

預計到 2024 年，臨床試驗用品市場規模將達到 33.1 億美元，到 2025 年將達到 35.4 億美元，到 2033 年將達到 60.3 億美元，預測期（2026-2033 年）的複合年成長率為 6.9%。

由於藥物研發成本上升、供應策略改善以及生物製藥處理標準日益嚴格，臨床試驗用品市場正經歷顯著成長。推動這一成長的關鍵因素包括製藥和生物製藥公司研發投入的增加、臨床試驗數量的成長以及已開發地區藥物研發成本的上升。儘管存在這些成長要素，但藥物研發成本的上升以及全球健康危機的挑戰可能會阻礙市場發展。全球慢性病盛行率的上升也進一步推動了這個市場趨勢。此外，提供外包解決方案的契約製造和服務供應商透過簡化開發流程、促進合作以及確保高效的物流和配送，幫助製藥公司，從而促進了臨床試驗用品市場的成長。

臨床試驗用品市場促進因素

精準醫療的日益普及正對全球臨床試驗用品市場產生重大影響。隨著治療方案越來越注重個人化，對創新治療方法和生物製藥的需求也日益成長。這種轉變推動了對專業臨床試驗材料開發和供應的需求，以應對複雜的臨床試驗設計和患者族群的細微差別。個人化醫療與先進調查方法的融合正在推動臨床試驗用品產業的成長，相關人員致力於確保為不同患者群體提供個人化且有效的治療方案。

臨床試驗用品市場的限制

全球臨床試驗耗材市場面臨供應鏈中斷帶來的嚴峻挑戰。地緣政治緊張局勢、自然災害和公共衛生危機等因素會嚴重影響必要物資的供應和運輸物流。這些中斷往往會導致臨床試驗啟動延遲，增加營運成本，並最終阻礙整體臨床研究活動的效率。因此，市場相關人員必須克服這些障礙，以確保臨床試驗的完整性和進展，並及時有效地進行試驗。

臨床試驗用品市場趨勢

隨著技術進步推動去中心化臨床試驗的興起，臨床試驗用品市場正經歷重大變革。這種向虛擬試驗和遠端患者監護的轉變，擴大了受試者的可近性，增加了臨床試驗的多樣性，同時降低了營運成本。因此，試驗週期正在縮短，傳統的調查方法也發生了根本性的改變。隨著業界積極擁抱這些創新，以患者為中心的理念日益受到重視，從而提高了受試者的參與度和依從性。這一趨勢不僅提高了臨床試驗的可行性和效率，也為市場未來的持續成長和發展奠定了基礎。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析

全球臨床試驗用品市場規模（依階段分類）及複合年成長率（2026-2033 年）

• 第一階段
• 第二階段
• 第三階段
• 其他

全球臨床試驗用品市場規模（依產品及服務分類）及複合年成長率（2026-2033 年）

• 製造業
• 倉儲和配送
• 供應鏈管理

全球臨床試驗用品市場規模（按最終用途和複合年成長率分類）（2026-2033 年）

• 製藥
• 生物製藥
• 醫療設備
• 其他

全球臨床試驗用品市場規模（依治療領域分類）及複合年成長率（2026-2033 年）

• 腫瘤學
• 中樞神經系統（CNS）
• 循環系統
• 感染疾病
• 代謝性疾病
• 其他

全球臨床試驗用品市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Almac Group（UK）
• Thermo Fisher Scientific Inc.（USA）
• Marken（UPS）（USA）
• PCI Pharma Services（USA）
• Sharp Services LLC（USA）
• Cencora, Inc.（USA）
• Myonex（USA）
• Clinigen Limited（UK）
• Inceptua Group（Luxembourg）
• Eurofins Scientific（Luxembourg）
• IQVIA（USA）
• Parexel International Corporation（USA）
• ICON plc（Ireland）
• Catalent, Inc.（USA）
• Piramal Pharma Solutions（India）
• Biocair（UK）
• Lonza（Switzerland）
• World Courier（USA）
• Klifo A/S（Denmark）
• DHL Supply Chain（Germany）

結論與建議

Clinical Trial Supplies Market size was valued at USD 3.31 Billion in 2024 and is poised to grow from USD 3.54 Billion in 2025 to USD 6.03 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The clinical trial supplies market is witnessing significant growth driven by escalating drug research costs and the need for enhanced supply strategies and stricter handling standards for biopharmaceutical products. Key factors fueling this expansion include increased R&D investment by pharmaceutical and biopharmaceutical companies, a rising number of clinical trials, and heightened drug development expenses in developed regions. Despite these growth drivers, rising costs associated with drug research and challenges posed by global health crises may hinder market advancements. The growing prevalence of chronic diseases globally further supports this market trend. Additionally, contract manufacturers and service providers offering outsourcing solutions empower pharmaceutical companies by streamlining development processes, facilitating collaboration, and ensuring efficient logistics and distribution, thereby contributing to market growth in clinical trial supplies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trial Supplies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Trial Supplies Market Segments Analysis

Global Clinical Trial Supplies Market is segmented by Phase, Products and Services, End Use, Therapeutic and region. Based on Phase, the market is segmented into Phase I, Phase II, Phase III and Others. Based on Products and Services, the market is segmented into Manufacturing, Storage and Distribution and Supply Chain Management. Based on End Use, the market is segmented into Pharmaceutical, Biologics, Medical device and Others. Based on Therapeutic, the market is segmented intooncology, CNS, Cardiovascular, Infectious disease, Metabolic disorders and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Clinical Trial Supplies Market

A significant influence on the global clinical trial supplies market is the heightened emphasis on precision medicine. As treatments increasingly target individual patients, there is an escalating demand for innovative therapies and biologic medications. This shift necessitates the development and supply of specialized clinical trial materials to accommodate the intricate designs of clinical trials and the nuances of patient stratification. The convergence of personalized therapies and advanced trial methodologies drives the growth of the clinical trial supplies sector, as stakeholders seek to ensure the delivery of tailored and effective treatment options for diverse patient populations.

Restraints in the Clinical Trial Supplies Market

The global clinical trial supplies market faces significant challenges due to disruptions in the supply chain. Factors such as geopolitical tensions, natural disasters, and public health crises can severely impact the availability of necessary materials and the logistics of transportation. These interruptions often lead to delays in the initiation of clinical trials and can increase operational expenses, ultimately hindering the overall efficiency of clinical research activities. As a result, stakeholders within the market must navigate these obstacles to ensure timely and effective execution of their trials, maintaining the integrity and progress of clinical studies.

Market Trends of the Clinical Trial Supplies Market

The Clinical Trial Supplies market is experiencing a significant transformation driven by the rise of decentralized clinical trials, fueled by advancements in technology. This shift towards virtual studies and remote patient monitoring is expanding participant accessibility, thereby enhancing diversity in clinical trials while simultaneously reducing operational costs. Consequently, there is an acceleration in trial timelines, fundamentally altering traditional research methodologies. As the industry embraces these innovations, the focus on patient-centric approaches is growing, fostering greater engagement and compliance. This trend not only increases the feasibility and efficiency of clinical trials but also positions the market for sustainable growth and evolution in the future.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Clinical Trial Supplies Market Size by Phase & CAGR (2026-2033)

• Market Overview
• Phase I
• Phase II
• Phase III
• Others

Global Clinical Trial Supplies Market Size by Products and Services & CAGR (2026-2033)

• Market Overview
• Manufacturing
• Storage and Distribution
• Supply Chain Management

Global Clinical Trial Supplies Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Pharmaceutical
• Biologics
• Medical device
• Others

Global Clinical Trial Supplies Market Size by Therapeutic & CAGR (2026-2033)

• Market Overview
• Oncology
• CNS
• Cardiovascular
• Infectious disease
• Metabolic disorders
• Others

Global Clinical Trial Supplies Market Size & CAGR (2026-2033)

• North America (Phase, Products and Services, End Use, Therapeutic)
  • US
  • Canada
• Europe (Phase, Products and Services, End Use, Therapeutic)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Phase, Products and Services, End Use, Therapeutic)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Phase, Products and Services, End Use, Therapeutic)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Phase, Products and Services, End Use, Therapeutic)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Almac Group (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marken (UPS) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PCI Pharma Services (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sharp Services LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cencora, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myonex (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinigen Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inceptua Group (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Pharma Solutions (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocair (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• World Courier (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Klifo A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DHL Supply Chain (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations